Banding Versus Propranolol for Primary Prophylaxis of Variceal Bleeding
Randomized Study Comparing Ligation With Propranolol for Primary Prophylaxis of Variceal Bleeding in Candidates for Liver Transplantation
Sponsor: University of Padova
Terminated
From the interim analysis resulted that more than 1000 patients were required to demonstrate a significant difference between the 2 treatments.
Other terminated trials from University of Padova
- Antiphospholipid Syndrome · Phase PHASE3 · Jan 2018
- Ascites · Phase PHASE2/PHASE3 · Jul 2014
- Cirrhosis · Phase PHASE2/PHASE3 · Oct 2013
More terminations from University of Padova
This PHASE3 trial investigates Esophageal Varices and Liver Cirrhosis and is currently terminated or withdrawn. University of Padova leads this study, which shows 10 recorded versions since 2026 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE3
▶ Show 5 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE3
-
Jun 2018 — Nov 2020 [monthly]
Terminated PHASE3
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE3
-
Aug 2017 — May 2018 [monthly]
Terminated PHASE3
-
Jan 2017 — Aug 2017 [monthly]
Terminated PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Padova
For direct contact, visit the study record on ClinicalTrials.gov .